SMARCA5 and prostate carcinoma: Previous studies have shown that QKI binds upstream and downstream of SMARCA5, ZEB1 and NDUFB2 RNA to promote circRNA formation in lung cancer [56], prostate cancer [57], and hepatocellular carcinoma [58].